China Envoy Gao Blasts U.S. at Vienna Drug Meeting as Fentanyl Deaths Fell Nearly 50%
Updated
Updated · dominotheory.com · May 12
China Envoy Gao Blasts U.S. at Vienna Drug Meeting as Fentanyl Deaths Fell Nearly 50%
1 articles · Updated · dominotheory.com · May 12
Gao Wei used a March Vienna narcotics meeting to accuse the U.S. of using drug control as a pretext for unilateral bullying and interference in other countries’ internal affairs, rebutting U.S. claims about China’s weak chemical export controls.
Sara Carter, the Trump administration’s drug czar, had told the same conference that China manufactures precursor chemicals in massive volumes and that lax enforcement lets suppliers work with Mexican cartels.
The clash came after signs of limited cooperation: China announced new precursor-export restrictions after an unacknowledged November Beijing visit by FBI Director Kash Patel, even as public rhetoric hardened again in Vienna.
The broader backdrop is a sharp fentanyl supply shock in North America—research cited in the report links tighter Chinese controls and U.S. pressure to falling purity and seizures, with U.S. fentanyl deaths down nearly half by September 2025.
With Trump expected to meet Xi in Beijing later this week, fentanyl is on the agenda but risks being overshadowed by other disputes, underscoring how fragile counternarcotics cooperation remains.
As China restricts chemical exports, will new narco-hubs emerge elsewhere to supply the world's fentanyl demand?
Can the 1980s playbook for quaaludes truly defeat today’s far more lethal and adaptable fentanyl crisis?